Journal of Clinical Epidemiology
Volume 50, Issue 5 , Pages 619-625 , May 1997

Validation of pharmacy records in drug exposure assessment

  • Hong S. Lau
    • ,
  • Anthonius de Boer

      Affiliations

    • Corresponding Author InformationAddress for correspondence: A. de Boer, MD, PhD, Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University University, P.O. Box 80082, 3508 TB Utrecht, The Netherlands.
    • ,
  • Karin S. Beuning
    • ,
  • Arijan Porsius

,Accepted 25 November 1996.

References 

  1. Rothman KJ. In: 2nd ed. Modern Epidemiology. Boston: Little, Brown and Company; 1986;
  2. Carson JL, Strom BL. Medicaid databases. In:  Strom B editors. Pharmacoepidemiology. 2nd ed. Chichester: John Wiley & Sons; 1994;p. 199–216
  3. Friedman GD. Kaiser Permanente Medical Care Program: Northern California and Other Regions. In:  Strom B editors. Pharmacoepidemiology. 2nd ed. Chichester: John Wiley & Sons; 1994;p. 187–198
  4. Strand LM, Downey W. Health databases in Saskatchewan. In:  Strom B editors. Pharmacoepidemiology. 2nd ed. Chichester: John Wiley & Sons; 1994;p. 217–230
  5. Herings RMC. PHARMO; a record linkage system for postmarketing surveillance of prescription drugs in the Netherlands. In: 2nd ed. Dissertation. Utrecht University; 1993;
  6. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol. 1982;116:114–122
  7. Lessler BL, Harris BSH. In: 2nd ed. Medicaid Data as a Source for Postmarketing Surveillance Information. Final Report. Research Triangle Park, NC: Research Triangle Institute; 1984;
  8. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995;48:999–1009
  9. Stergachis AS. Evaluating the quality of linked automated databases for use in pharmacoepidemiology. In:  Hartzema AG,  Porta MS,  Tilson HH editor. Pharmacoepidemiology: An Introduction. 2nd ed. Cincinnati: Harvey Whitney Books Company; 1991;p. 222–234
  10. Heerdink ER, Leufkens HG, Koppedraaijer C, Bakker A. Information on drug use in the elderly: A comparison of pharmacy, general practitioner and patient data. Pharm Weekbl [Sci]. 1995;17:20–24
  11. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc. 1991;39:1079–1084
  12. van Staa TP, Abenhaim L, Leufkens H. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. J Clin Epidemiol. 1994;47:183–189
  13. West SL, Strom BL, Freundlich B, Normand E, Koch G, Savitz DA, et al.  Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol. 1994;47:165–171
  14. Strom BL, Carson JL, Halpern AC. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med. 1991;10:565–576
  15. Guess HA, West R, Strand LM, et al.  Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan. J Clin Epidemiol. 1988;41:35–45
  16. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy. Ann Pharmacother. 1994;28:99–104
  17. Shapiro S. The role of automated record linkage in the postmarketing surveillance of drug safety: A critique. Clin Pharmacol Ther. 1989;46:371–386
  18. Leufkens HGM. Pharmacy Records in Pharmacoepidemiology: Studies on Antiinflammatory and Antirheumatic Drugs. In: Dissertation. Utrecht University; 1990;
  19. WHO . In: Guidelines for ATC Classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology—Nordic Council on Medicines; 1990;
  20. Herings RMC, Deboer A, Stricker BHC, Leufkens HGM, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 1995;345:1195–1198
  21. Visser LE, Stricker BHC, Vandervelden J, Paes AHP, Bakker A. Angiotensin converting enzyme inhibitor associated cough: A population-based case-control study. J Clin Epidemiol. 1995;48:851–857
  22. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987;316:363–369
  23. Carson JL, Strom BL, Duff A, et al.  Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Int Med. 1993;119:576–583
  24. Spriet A, Beiler D, Dechorgnat J, Simon P. Adherence of elderly patients to treatment with pentoxifylline. Clin Pharmacol Ther. 1980;27:1–8
  25. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Quellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273–3277
  26. Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther. 1988;44:540–545

PII: S0895-4356(97)00040-1

Journal of Clinical Epidemiology
Volume 50, Issue 5 , Pages 619-625 , May 1997

Article Tools